Molecular changes in pre-metastatic lymph nodes of esophageal cancer patients. 2014

Benjamin Otto, and Alexandra M Koenig, and Genrich V Tolstonog, and Anke Jeschke, and Kristin Klaetschke, and Yogesh K Vashist, and Daniel Wicklein, and Christoph Wagener, and Jakob R Izbicki, and Thomas Streichert
Department of Internal Medicine, Center for Internal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Department of Clinical Chemistry, Center for Diagnostic, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Lymph node metastasis indicates poor prognosis in esophageal cancer. To understand the underlying mechanisms, most studies so far focused on investigating the tumors themselves and/or invaded lymph nodes. However they neglected the potential events within the metastatic niche, which precede invasion. Here we report the first description of these regulations in patients on transcription level. We determined transcriptomic profiles of still metastasis-free regional lymph nodes for two patient groups: patients classified as pN1 (nā€Š=ā€Š9, metastatic nodes exist) or pN0 (nā€Š=ā€Š5, no metastatic nodes exist). All investigated lymph nodes, also those from pN1 patients, were still metastasis-free. The results show that regional lymph nodes of pN1 patients differ decisively from those of pN0 patients--even before metastasis has taken place. In the pN0 group distinct immune response patterns were observed. In contrast, lymph nodes of the pN1 group exhibited a clear profile of reduced immune response and reduced proliferation, but increased apoptosis, enhanced hypoplasia and morphological conversion processes. DKK1 was the most significant gene associated with the molecular mechanisms taking place in lymph nodes of patients suffering from metastasis (pN1). We assume that the two molecular profiles observed constitute different stages of a progressive disease. Finally we suggest that DKK1 might play an important role within the mechanisms leading to lymph node metastasis.

UI MeSH Term Description Entries
D008198 Lymph Nodes They are oval or bean shaped bodies (1 - 30 mm in diameter) located along the lymphatic system. Lymph Node,Node, Lymph,Nodes, Lymph
D008207 Lymphatic Metastasis Transfer of a neoplasm from its primary site to lymph nodes or to distant parts of the body by way of the lymphatic system. Lymph Node Metastasis,Lymph Node Metastases,Lymphatic Metastases,Metastasis, Lymph Node
D004938 Esophageal Neoplasms Tumors or cancer of the ESOPHAGUS. Cancer of Esophagus,Esophageal Cancer,Cancer of the Esophagus,Esophagus Cancer,Esophagus Neoplasm,Neoplasms, Esophageal,Cancer, Esophageal,Cancer, Esophagus,Cancers, Esophageal,Cancers, Esophagus,Esophageal Cancers,Esophageal Neoplasm,Esophagus Cancers,Esophagus Neoplasms,Neoplasm, Esophageal,Neoplasm, Esophagus,Neoplasms, Esophagus
D004947 Esophagus The muscular membranous segment between the PHARYNX and the STOMACH in the UPPER GASTROINTESTINAL TRACT.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015972 Gene Expression Regulation, Neoplastic Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action in neoplastic tissue. Neoplastic Gene Expression Regulation,Regulation of Gene Expression, Neoplastic,Regulation, Gene Expression, Neoplastic
D059467 Transcriptome The pattern of GENE EXPRESSION at the level of genetic transcription in a specific organism or under specific circumstances in specific cells. Transcriptomes,Gene Expression Profiles,Gene Expression Signatures,Transcriptome Profiles,Expression Profile, Gene,Expression Profiles, Gene,Expression Signature, Gene,Expression Signatures, Gene,Gene Expression Profile,Gene Expression Signature,Profile, Gene Expression,Profile, Transcriptome,Profiles, Gene Expression,Profiles, Transcriptome,Signature, Gene Expression,Signatures, Gene Expression,Transcriptome Profile
D036341 Intercellular Signaling Peptides and Proteins Regulatory proteins and peptides that are signaling molecules involved in the process of PARACRINE COMMUNICATION. They are generally considered factors that are expressed by one cell and are responded to by receptors on another nearby cell. They are distinguished from HORMONES in that their actions are local rather than distal. Growth Factor,Growth Factors,Paracrine Peptide Factors,Paracrine Protein Factors,Factor, Growth,Factors, Growth,Peptide Factors, Paracrine

Related Publications

Benjamin Otto, and Alexandra M Koenig, and Genrich V Tolstonog, and Anke Jeschke, and Kristin Klaetschke, and Yogesh K Vashist, and Daniel Wicklein, and Christoph Wagener, and Jakob R Izbicki, and Thomas Streichert
May 2020, World journal of surgical oncology,
Benjamin Otto, and Alexandra M Koenig, and Genrich V Tolstonog, and Anke Jeschke, and Kristin Klaetschke, and Yogesh K Vashist, and Daniel Wicklein, and Christoph Wagener, and Jakob R Izbicki, and Thomas Streichert
January 1991, Sovetskaia meditsina,
Benjamin Otto, and Alexandra M Koenig, and Genrich V Tolstonog, and Anke Jeschke, and Kristin Klaetschke, and Yogesh K Vashist, and Daniel Wicklein, and Christoph Wagener, and Jakob R Izbicki, and Thomas Streichert
March 2005, American journal of surgery,
Benjamin Otto, and Alexandra M Koenig, and Genrich V Tolstonog, and Anke Jeschke, and Kristin Klaetschke, and Yogesh K Vashist, and Daniel Wicklein, and Christoph Wagener, and Jakob R Izbicki, and Thomas Streichert
February 2005, Clinical cancer research : an official journal of the American Association for Cancer Research,
Benjamin Otto, and Alexandra M Koenig, and Genrich V Tolstonog, and Anke Jeschke, and Kristin Klaetschke, and Yogesh K Vashist, and Daniel Wicklein, and Christoph Wagener, and Jakob R Izbicki, and Thomas Streichert
June 2020, Surgical oncology,
Benjamin Otto, and Alexandra M Koenig, and Genrich V Tolstonog, and Anke Jeschke, and Kristin Klaetschke, and Yogesh K Vashist, and Daniel Wicklein, and Christoph Wagener, and Jakob R Izbicki, and Thomas Streichert
July 2013, World journal of surgical oncology,
Benjamin Otto, and Alexandra M Koenig, and Genrich V Tolstonog, and Anke Jeschke, and Kristin Klaetschke, and Yogesh K Vashist, and Daniel Wicklein, and Christoph Wagener, and Jakob R Izbicki, and Thomas Streichert
January 2009, European journal of gynaecological oncology,
Benjamin Otto, and Alexandra M Koenig, and Genrich V Tolstonog, and Anke Jeschke, and Kristin Klaetschke, and Yogesh K Vashist, and Daniel Wicklein, and Christoph Wagener, and Jakob R Izbicki, and Thomas Streichert
September 1967, Rocky Mountain medical journal,
Benjamin Otto, and Alexandra M Koenig, and Genrich V Tolstonog, and Anke Jeschke, and Kristin Klaetschke, and Yogesh K Vashist, and Daniel Wicklein, and Christoph Wagener, and Jakob R Izbicki, and Thomas Streichert
January 2017, Medical science monitor : international medical journal of experimental and clinical research,
Benjamin Otto, and Alexandra M Koenig, and Genrich V Tolstonog, and Anke Jeschke, and Kristin Klaetschke, and Yogesh K Vashist, and Daniel Wicklein, and Christoph Wagener, and Jakob R Izbicki, and Thomas Streichert
September 1999, Clinical cancer research : an official journal of the American Association for Cancer Research,
Copied contents to your clipboard!